IL-22 Attenuates Pressure Overload-Induced Heart Failure and Inflammation
Authors:
- 7 April 2025
- journal article
- research article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 18 (3) , 471-483
Abstract
Heart failure (HF) due to left ventricular (LV) dysfunction remains a major global health challenge, with inflammation driving its progression under chronic pressure overload, such as hypertension. This study explored the role of interleukin-22 (IL-22), a cytokine associated with tissue protection, in HF induced by transverse aortic constriction (TAC). IL-22 knockout (KO) mice exhibited exacerbated HF, marked by worsened LV hypertrophy, heightened inflammation, and impaired cardiac function compared to wild-type controls. Conversely, treatment with recombinant IL-22Fc improved LV function, reduced inflammatory cell infiltration, and alleviated cardiac remodeling and inflammation. These findings demonstrate that IL-22 plays a critical role in regulating inflammation and cardiac remodeling in pressure overload-induced HF. Targeting IL-22 may represent a promising therapeutic strategy to alleviate HF progression and associated pulmonary complications. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (82100395, 82370357)
- National Key Research and Development Project of China (2021YFC250050, 2023YFC2506500)
- Program of Shanghai Academic Research Leader (22XD1423300)
This publication has 30 references indexed in Scilit:
- Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophyBasic Research in Cardiology, 2017
- T cell costimulation blockade blunts pressure overload-induced heart failureNature Communications, 2017
- CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and LungsHypertension, 2016
- RORγt+ IL-22-producing NKp46+ cells protect from hepatic ischemia reperfusion injury in miceJournal of Hepatology, 2016
- Interleukin-22: Immunobiology and PathologyAnnual Review of Immunology, 2015
- IL-22 Ameliorates Renal Ischemia-Reperfusion Injury by Targeting Proximal Tubule EpitheliumJournal of the American Society of Nephrology, 2014
- Therapeutic opportunities of the IL-22–IL-22R1 systemNature Reviews Drug Discovery, 2013
- Inflammatory Cytokines in Heart Failure: Mediators and MarkersCardiology, 2012
- IL-22 Increases the Innate Immunity of TissuesImmunity, 2004
- Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-α Promote Progressive Left Ventricular Dysfunction and Remodeling in RatsCirculation, 1998